We are live on ! Find out more
GCTK icon

GlucoTrack
GCTK

1 hedge funds and large institutions have $68K invested in GlucoTrack in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

29% less capital invested

Capital invested by funds: $96K → $68K (-$28K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boston Financial Management
Massachusetts
$68K – – –

GCTK Hedge Fund Activity: Q2 2022 in Review

1 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2022, worth a combined $68K — down 29% from $96K a quarter earlier.

Fund positioning in GCTK was balanced in Q2 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held GlucoTrack (GCTK) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $68K of GlucoTrack stock for Q2 2022, down 29% quarter-over-quarter.
  • 0 funds opened new GlucoTrack positions in Q2 2022 and 0 closed out.

Based on aggregated 13F filings for Q2 2022.